Excellent results with a simple shot in the arm -and minimal side effects. This is the type of treatment that we need access to now - not years from now.
https://globenewswire.com/news-release/2018/05/21/1509287/0/en/MimiVax-Announces-Positive-Interim-Results-from-Phase-II-Trial-of-SurVaxM-Immunotherapy-for-the-Treatment-of-Newly-Diagnosed-Glioblastoma.html
